0001104659-24-058588.txt : 20240508 0001104659-24-058588.hdr.sgml : 20240508 20240508133827 ACCESSION NUMBER: 0001104659-24-058588 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240331 FILED AS OF DATE: 20240508 DATE AS OF CHANGE: 20240508 EFFECTIVENESS DATE: 20240508 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RiverVest Venture Management LLC CENTRAL INDEX KEY: 0001812549 ORGANIZATION NAME: IRS NUMBER: 431900629 STATE OF INCORPORATION: MO FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-21321 FILM NUMBER: 24925189 BUSINESS ADDRESS: STREET 1: 101 S. HANLEY ROAD STREET 2: SUITE 1850 CITY: ST. LOUIS STATE: MO ZIP: 63105 BUSINESS PHONE: 314-726-6700 MAIL ADDRESS: STREET 1: 101 S. HANLEY ROAD STREET 2: SUITE 1850 CITY: ST. LOUIS STATE: MO ZIP: 63105 13F-HR 1 primary_doc.xml X0202 13F-HR LIVE false false false 0001812549 XXXXXXXX 03-31-2024 03-31-2024 false RiverVest Venture Management LLC
101 S. Hanley Road Suite 1850 St. Louis MO 63105
13F HOLDINGS REPORT 028-21321 N
Sivan Weitzman Chief Financial Officer 314-726-6700 /s/ Sivan Weitzman St. Louis MO 02-12-2024 0 4 8141025
INFORMATION TABLE 2 infotable.xml Spruce Bioscience, Inc. Common 85209E109 2307624 2936281 SH SOLE 2936281 0 0 Vapotherm, Inc. Common 922107107 69806 52881 SH OTR 0 52881 0 Reneo Pharmaceuticals, Inc. Common 75974E103 4206805 2534220 SH SOLE 2534220 0 0 Xilio Therapeutics, Inc. Common 98422T100 1556790 1441444 SH SOLE 1441444 0 0